Chimeric proteins
US10507236B2 · kind B2 · utility
0Cited by
1References
13Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 9, 2015 |
| Grant date | Dec 17, 2019 |
| Priority date | — |
| Expiry date | Oct 9, 2035 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention is directed generally to chimeric proteins that can facilitate targeting of nanoparticulate carriers to antigen presenting cells, and to nanoparticulate carriers comprising these chimeric proteins. The invention is also directed to methods of internalizing an antigen in an antigen presenting cell, and methods of eliciting an immune response to an antigen in a subject, using the nanoparticulate carriers comprising the chimeric proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.